ENvue Medical, Inc. Gross Profit

• ENvue Medical, Inc. showed a decrease of -1.9% in Gross Profit from 2023 to 2024.
• This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2014: $39.0 thousand | Q3 2014: -$10.0 thousand | Q1 2015: $19.0 thousand | Q2 2015: $24.0 thousand | Q3 2015: $30.0 thousand | Q1 2016: $30.0 thousand | Q2 2016: $40.0 thousand | Q3 2016: $34.0 thousand | Q1 2017: $36.0 thousand | Q2 2017: $34.0 thousand | Q3 2017: $43.0 thousand | Q1 2018: $55.0 thousand | Q2 2018: $77.0 thousand | Q3 2018: $8.0 thousand | Q1 2019: $53.0 thousand | Q2 2019: $207.0 thousand | Q3 2019: $47.0 thousand | Q1 2020: $51.0 thousand | Q2 2020: $38.0 thousand | Q3 2020: $99.0 thousand | Q1 2021: $77.0 thousand | Q2 2021: $208.0 thousand | Q3 2021: $228.0 thousand | Q1 2022: $106.0 thousand | Q2 2022: $281.0 thousand | Q3 2022: $80.0 thousand | Q1 2023: $235.0 thousand | Q2 2023: $216.0 thousand | Q3 2023: $349.0 thousand | Q1 2024: $664.0 thousand | Q2 2024: $428.0 thousand | Q3 2024: $133.0 thousand | Q1 2025: $369.0 thousand | Q2 2025: -$35.0 thousand | Q3 2025: $189.0 thousand.
• Over the full 11 years of available data (2014 to 2024), ENvue Medical, Inc.'s Gross Profit has grown by 1,270.9%.
• Historical annual values: Fiscal year 2024: $1.51 million | Fiscal year 2023: $1.54 million | Fiscal year 2022: $167.0 thousand | Fiscal year 2021: $770.0 thousand | Fiscal year 2020: $214.0 thousand | Fiscal year 2019: $281.0 thousand | Fiscal year 2018: $160.0 thousand | Fiscal year 2017: $151.0 thousand | Fiscal year 2016: $141.0 thousand | Fiscal year 2015: $98.0 thousand | Fiscal year 2014: $110.0 thousand.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026